Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study

Author:

Dekeyser CathérineORCID,Hautekeete Matthias,Cambron Melissa,Van Pesch Vincent,Patti FrancescoORCID,Kuhle JensORCID,Khoury Samia,Lechner Scott Jeanette,Gerlach Oliver,Lugaresi AlessandraORCID,Maimone Davide,Surcinelli Andrea,Grammond Pierre,Kalincik TomasORCID,Habek Mario,Willekens Barbara,Macdonell Richard,Lalive Patrice,Csepany Tunde,Butzkueven Helmut,Boz Cavit,Tomassini Valentina,Foschi MatteoORCID,Sánchez-Menoyo José Luis,Altintas Ayse,Mrabet Saloua,Iuliano Gerardo,Sa Maria Jose,Alroughani Raed,Karabudak Rana,Aguera-Morales EduardoORCID,Gray Orla,de Gans Koen,van der Walt AnnekeORCID,McCombe Pamela AORCID,Deri Norma,Garber Justin,Al-Asmi Abdullah,Skibina Olga,Duquette Pierre,Cartechini Elisabetta,Spitaleri DanieleORCID,Gouider RiadhORCID,Soysal Aysun,Van Hijfte Liesbeth,Slee Mark,Amato Maria Pia,Buzzard Katherine,Laureys Guy

Abstract

BackgroundIt remains unclear whether routine cerebrospinal fluid (CSF) parameters can serve as predictors of multiple sclerosis (MS) disease course.MethodsThis large-scale cohort study included persons with MS with CSF data documented in the MSBase registry. CSF parameters to predict time to reach confirmed Expanded Disability Status Scale (EDSS) scores 4, 6 and 7 and annualised relapse rate in the first 2 years after diagnosis (ARR2) were assessed using (cox) regression analysis.ResultsIn total, 11 245 participants were included of which 93.7% (n=10 533) were persons with relapsing-remitting MS (RRMS). In RRMS, the presence of CSF oligoclonal bands (OCBs) was associated with shorter time to disability milestones EDSS 4 (adjusted HR=1.272 (95% CI, 1.089 to 1.485), p=0.002), EDSS 6 (HR=1.314 (95% CI, 1.062 to 1.626), p=0.012) and EDSS 7 (HR=1.686 (95% CI, 1.111 to 2.558), p=0.014). On the other hand, the presence of CSF pleocytosis (≥5 cells/µL) increased time to moderate disability (EDSS 4) in RRMS (HR=0.774 (95% CI, 0.632 to 0.948), p=0.013). None of the CSF variables were associated with time to disability milestones in persons with primary progressive MS (PPMS). The presence of CSF pleocytosis increased ARR2 in RRMS (adjusted R2=0.036, p=0.015).ConclusionsIn RRMS, the presence of CSF OCBs predicts shorter time to disability milestones, whereas CSF pleocytosis could be protective. This could however not be found in PPMS. CSF pleocytosis is associated with short-term inflammatory disease activity in RRMS. CSF analysis provides prognostic information which could aid in clinical and therapeutic decision-making.

Publisher

BMJ

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3